Lappe Mark

Average Profitability
<0.0001%
Insider Buys Quantity
15
Insider Buys Sum
$14.43M
Insider Sells Quantity
6
Insider Sells Sum
$2.82M

Insider Activity of Lappe Mark

According to the SEC Form 4 filings, Lappe Mark, being in a position of

  1. Chief Executive Officer at Inhibrx Biosciences, Inc.,
    оver the last 12 months, has bought 84000 shares for $1.3M, and sold 0 shares,
    over all time since 2022-10-17, has bought 84000 shares for $1.3M, and sold 104060 shares for $2.82M.

The largest purchase of all time was on 2008-10-02 and amounted to 1846154 shares of Royalty Pharma plc for $12M.

The largest sale of all time was on 2022-10-17 and amounted to 26000 shares of Inhibrx Biosciences, Inc. for $769,443.

Biography of Lappe Mark

No biography is available at this moment.

2024-09-16PurchaseInhibrx, Inc.
INBX
Chief Executive Officer
13,037
0.0885%
$17.13$223,324-11.02%
2024-09-12PurchaseInhibrx, Inc.
INBX
Chief Executive Officer
26,963
0.1859%
$15.05$405,793+3.02%
2024-09-10PurchaseInhibrx, Inc.
INBX
Chief Executive Officer
8,500
0.0588%
$15.19$129,115+2.24%
2024-09-09PurchaseInhibrx, Inc.
INBX
Chief Executive Officer
9,500
0.0657%
$15.21$144,495+2.04%
2024-09-06PurchaseInhibrx, Inc.
INBX
Chief Executive Officer
26,000
0.1824%
$15.29$397,540+2.92%
2023-02-28SaleInhibrx, Inc.
INBX
Chief Executive Officer
60
0.0002%
$25.02$1,501-4.75%
2023-01-24SaleInhibrx, Inc.
INBX
Chief Executive Officer
4,335
0.0103%
$25.72$111,478-15.28%
2023-01-23SaleInhibrx, Inc.
INBX
Chief Executive Officer
21,665
0.0538%
$25.36$549,364-10.09%
2022-12-19SaleInhibrx, Inc.
INBX
Chief Executive Officer
26,000
0.06%
$25.56$664,443-10.85%
2022-11-17SaleInhibrx, Inc.
INBX
Chief Executive Officer
26,000
0.0574%
$27.88$724,910-20.77%
2022-10-17SaleInhibrx, Inc.
INBX
Chief Executive Officer
26,000
0.0593%
$29.59$769,443-20.23%
2008-10-31PurchaseRoyalty Pharma plc
RPRX
11,300
0.0007%
$7.76$87,688
2008-10-29PurchaseRoyalty Pharma plc
RPRX
24,400
0.0014%
$6.97$170,068
2008-10-28PurchaseRoyalty Pharma plc
RPRX
9,892
0.0006%
$6.87$67,958
2008-10-27PurchaseRoyalty Pharma plc
RPRX
14,825
0.0009%
$6.85$101,551
2008-10-24PurchaseRoyalty Pharma plc
RPRX
30,000
0.0017%
$6.89$206,700
2008-10-23PurchaseRoyalty Pharma plc
RPRX
17,309
0.0009%
$6.32$109,393
2008-10-17PurchaseRoyalty Pharma plc
RPRX
30,000
0.0016%
$6.42$192,600
2008-10-13PurchaseRoyalty Pharma plc
RPRX
15,000
0.0009%
$6.82$102,300
2008-10-10PurchaseRoyalty Pharma plc
RPRX
15,300
0.0008%
$6.23$95,319
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.